Koyfin Home > Directory > Health Care > Boston Scientific Corp > Total Debt / EBITDA

Boston Scientific Corp Total Debt / EBITDA Chart (BSX)

Boston Scientific Corp annual/quarterly Total Debt / EBITDA from 2010 to 2020.
  • Boston Scientific Corp Total Debt / EBITDA for the quarter ending September 09, 2020 was $4m a 22.71% increase of 1m year over year
  • Boston Scientific Corp Total Debt / EBITDA for the last 12 months ending September 09, 2020 was $4m a 17.86% increase of 1m year over year
  • Boston Scientific Corp Annual Total Debt / EBITDA for 2019 was $4m a 24.10% increase of 1m from 2018
  • Boston Scientific Corp Annual Total Debt / EBITDA for 2018 was $3m a 15.24% increase of 0m from 2017
  • Boston Scientific Corp Annual Total Debt / EBITDA for 2017 was $2m a -8.14% decrease of 0m from 2016
Other Ratios Metrics:
  • Boston Scientific Corp Total Debt / Capital for the quarter ending December 12, 2018 was $44m a -1.42% decrease of -1m year over year
  • Boston Scientific Corp Other Liabilities for the quarter ending September 09, 2018 was $2,202m a -16.30% decrease of -359m year over year
  • Boston Scientific Corp Total Debt / Equity for the quarter ending December 12, 2018 was $80m a -2.59% decrease of -2m year over year
View Chart On Koyfin

Quarterly BSX Total Debt / EBITDA Data

09/2020$4m
06/2020$9m
03/2020$5m
12/2019$3m
09/2019$4m
06/2019$4m
03/2019$3m
12/2018$2m
09/2018$3m
06/2018$3m

Annual BSX Total Debt / EBITDA Data

2019$4m
2018$3m
2017$2m
2016$2m
2015$3m
2014$3m
2013$3m
2012$3m
2011$2m
2010$3m